The accepted clinical practice of using beta blockers over the long term to curb the risk of further heart attacks or death doesn’t seem to be warranted in patients who don’t have heart failure, suggests a large study published in the journal Heart.
Study suggests psilocybin could help treat fear-based and other mental disorders
Post-traumatic stress disorder (PTSD) is a mental health condition triggered by a terrifying event. Its symptoms include flashbacks, nightmares, and severe anxiety. Most people experience PTSD at some point in their lives, with symptoms slowly resolving with time. For many, however, the symptoms are persistent, debilitating, and difficult to treat.
The nocebo effect may influence the side effects of the COVID-19 vaccine
People’s negative expectations and general attitudes towards the COVID-19 vaccine are significantly correlated with the occurrence and intensity of its most common side effects such as fatigue, muscle pain, headache and injection site pain. This is suggested by a study published in Psychological Science and led by scientists from the University of Bologna, who investigated how adverse effects reported after vaccination can be influenced by the nocebo effect, the opposite of the placebo effect.
Scientists study the mediating role of ‘FoMO’ given the trend towards ‘problematic smartphone use’ among adolescents
Researcher at the Department of Social Psychology of the University of Malaga Christiane Arrivillaga has participated in an international study conducted at the University of Toledo that aims to analyze how emotion dysregulation and FoMO—that is, the fear of missing out—together with a need to stay online to know what other people are doing, serve as factors to predict the possible problematic smartphone use among young people.
Apetamin: Using this illegal weight-gain product can bring tragic results
U.S. regulators are urging Americans to avoid Apetamin, an illegal drug used for weight gain and figure enhancement.
Study reveals systemic underdiagnosis and undertreatment of homozygous familial hypercholesterolemia
A new study from the Family Heart Foundation shows the diagnosis and treatment of homozygous familial hypercholesterolemia (HoFH) is delayed, and often occurs after a heart attack or early atherosclerotic cardiovascular disease (ASCVD).
Passing the sniff test: Can we train our brain to boost smell and memory?
A new study is investigating whether learning to remember smells can boost memory more broadly and reduce the risk of dementia.
Openseize: A novel open-source software to analyze large-scale digital signals
Electroencephalography (EEG) is an indispensable tool used by clinicians to diagnose neurological diseases and by researchers to study and discover brain circuit mechanisms that support sensory, mnemonic, and cognitive processing. A new software—Openseize—created by Dr. Matthew Caudill, an investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital and assistant professor at Baylor College of Medicine, can now analyze massive amounts of one-dimensional digital signals including huge EEG datasets. The study was published in the Journal for Open Source Software.
Scientists deliver siRNA therapy to lung
Scientists at UMass Chan Medical School have developed a technology to deliver gene therapy directly to lung tissue through intranasal administration, a development that could potentially create a new class of treatments for lung disease.
Dementia and self-harm: Why it’s crucial to support patients in first year after diagnosis
People diagnosed with dementia are more likely to self-harm within the first six to 12 months after initial diagnosis, highlighting the need for health services to offer more follow-up support in this crucial period.